{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/influenza-seasonal/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"b4d67dc6-a391-5644-a3a4-89c1c0c49e3f","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 10862bfd-65a4-47d1-a120-affefead4fdd --><h2>Update</h2><!-- end field 10862bfd-65a4-47d1-a120-affefead4fdd -->","summary":null,"htmlStringContent":"<!-- begin item e99e03fd-a790-454a-9d4e-2491a56b2d88 --><!-- end item e99e03fd-a790-454a-9d4e-2491a56b2d88 -->","topic":{"id":"7143131b-dc98-5d14-aef2-f50114a27d13","topicId":"c00149e5-18ab-49c6-8576-089384091df2","topicName":"Influenza - seasonal","slug":"influenza-seasonal","lastRevised":"Last revised in August 2020","chapters":[{"id":"415ca83c-583b-5dd7-8ce7-a67a72325836","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"39d27467-6801-59da-a28b-29a9a1aa848d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7326279e-c8e9-5783-9cb0-433a2e0c5061","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"ecde5124-7df2-5d70-921e-cfa13a752476","slug":"changes","fullItemName":"Changes"},{"id":"b4d67dc6-a391-5644-a3a4-89c1c0c49e3f","slug":"update","fullItemName":"Update"}]},{"id":"3b2a94ae-a366-5ff9-8a35-6f8eb63736a1","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8b66965c-fc03-5267-ac06-f0edc2bf81ea","slug":"goals","fullItemName":"Goals"},{"id":"32bc1d45-c0ea-55ed-8723-fdbf13b7196e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c5aa9558-010a-5b32-b95a-40f647ef373e","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b9c5c598-f72e-505f-b951-cbe710a6af02","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d0c6ad8d-5845-5dfd-b2d0-b04bb5395c62","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"48e0bfcd-fd33-552c-b052-28533a176218","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"feb6e56c-e4f6-57f4-bbee-0876089197e0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"bc17d7e2-a53a-595c-9f57-7080c9814001","slug":"definition","fullItemName":"Definition"},{"id":"d0475ee5-11e2-5ad5-8628-4f513e50236f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a0aabed4-a912-518e-9257-8653bc7541e4","slug":"complications","fullItemName":"Complications"}]},{"id":"f81fdd28-028a-5558-92b2-90a1569692bb","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"dcd79bc4-67e6-52b5-af13-ab18772e4c55","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"4da6c7b5-c872-551a-aff9-100bef3041ca","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"b540d9e5-48f5-5b1c-a8b1-8a37d951449f","fullItemName":"Management","slug":"management","subChapters":[{"id":"9cbc6ee5-b0da-5b46-9ce4-3704f7cf24a9","slug":"treating-influenza","fullItemName":"Scenario: Treating influenza"},{"id":"b82606d4-79c4-5b96-84cd-115c371c80b4","slug":"post-exposure-prophylaxis","fullItemName":"Scenario: Post-exposure prophylaxis"}]},{"id":"267c67be-5fb6-510f-b3f7-15ece61003d9","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"418c695e-c703-5e30-9ec2-9bf2afeb6001","slug":"oseltamivir","fullItemName":"Oseltamivir"},{"id":"370b7394-2bad-5d4f-ac2a-06de67bbefea","slug":"zanamivir","fullItemName":"Zanamivir"}]},{"id":"83f51ef5-d6f9-5101-849d-c72bd5975126","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"fe85159c-da36-5171-9b52-88d8edd9ee77","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"46f280be-d769-501b-905f-789bbf2d8454","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"9904923d-c7de-53aa-8253-15c9392ece2e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3790de44-d79a-5486-b053-d09c6dccc2cc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7e631b66-3030-5dd0-97e7-7504198b5a14","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ab624014-37fa-5613-976c-e2ffa65a7e90","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"85b4d3fc-b6de-5df4-ad98-bf9ea439e342","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"7326279e-c8e9-5783-9cb0-433a2e0c5061","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"cb836f23-4868-55df-9684-8c25778124a6","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field c0c5516d-c4b8-4f40-a69c-4a831320367e --><h3>New evidence</h3><!-- end field c0c5516d-c4b8-4f40-a69c-4a831320367e -->","summary":null,"htmlStringContent":"<!-- begin item c3d855ae-1a92-48eb-a3bc-61a45efff882 --><!-- begin field ef65c0f7-9b2d-42f0-ad2d-1265ff7d554b --><h3>Evidence-based guidelines</h3><!-- end field ef65c0f7-9b2d-42f0-ad2d-1265ff7d554b --><!-- begin field dc178573-683d-47b7-a3ac-f9debc1c10f1 --><ul><li>EMA (2019) <em>Update of EU recommendations for 2019–2020 seasonal flu vaccine composition. </em>European Medicines Agency. <a href=\"https://www.ema.europa.eu/en\" data-hyperlink-id=\"ac16ce7a-6b98-4135-9207-aa57009d8d21\">www.ema.europa.eu</a> [<a href=\"https://www.ema.europa.eu/en/news/update-eu-recommendations-2019-2020-seasonal-flu-vaccine-composition\" data-hyperlink-id=\"e0737291-9b6c-480d-9f3c-aa57009d8d39\">Free Full-text</a>]</li><li>Specialist Pharmacy Service (2019) <em>Written Instruction for the administration of seasonal ‘flu vaccination.</em> Specialist Pharmacy Service. <a href=\"https://www.sps.nhs.uk/\" data-hyperlink-id=\"71b60381-ce7b-4d95-831f-aa57009d8d46\">www.sps.nhs.uk</a> [<a href=\"https://www.sps.nhs.uk/articles/written-instruction-for-the-administration-of-seasonal-flu-vaccination/\" data-hyperlink-id=\"0fbfea51-4e85-4dc8-8545-aa57009d8d59\">Free Full-text</a>]</li><li>PHE (2019) <em>Flu vaccines for children.</em> Public Health England. <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"7d3f9e4c-cfe7-47b6-9178-aaaf0094816b\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/which-flu-vaccine-should-children-have#history\" data-hyperlink-id=\"f398dcd0-1f94-4fab-a705-aaaf0094817b\">Free Full-text</a>]</li><li>PHE (2019) <em>Influenza: treatment and prophylaxis using anti-viral agents. </em>Public Health England. <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"ce791ea9-1ae4-42f9-ac57-aae200c6d12c\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/influenza-treatment-and-prophylaxis-using-anti-viral-agents\" data-hyperlink-id=\"b70aa05f-a5ae-4ad5-bfe2-aae200c6d143\">Free Full-text</a>]</li><li>Chung, S-C., Providencia, R., Sofat, R. (2020) <em>Association between angiotensin blockade and incidence of influenza in the United Kingdom</em>. <a href=\"https://www.nejm.org/\" data-hyperlink-id=\"21690b32-a8e8-40a6-8ac9-abbc0097b771\">www.nejm.org</a> [<a href=\"https://www.nejm.org/doi/full/10.1056/NEJMc2005396\" data-hyperlink-id=\"c9bf081e-56ff-4e54-85f0-abbc0097b8c1\">Free Full-text</a>]</li><li>Specialist Pharmacy Service (2020) <em>Oseltamivir and zanamivir – can they be used in breastfeeding mothers for the treatment or prophylaxis of influenza?</em> <a href=\"https://www.sps.nhs.uk/\" data-hyperlink-id=\"449eaf1e-31c2-45ee-a6e6-ac1700af05b5\">www.sps.nhs.uk</a> [<a href=\"https://www.sps.nhs.uk/articles/oseltamivir-or-zanamivir-can-mothers-breastfeed-after-treatment-for-influenza-2/\" data-hyperlink-id=\"ddfa2dd2-71ae-4b94-b6b1-ac1700af05df\">Free Full-text</a>]</li></ul><!-- end field dc178573-683d-47b7-a3ac-f9debc1c10f1 --><!-- begin field e55de209-9524-4b59-915b-25ccf47e812b --><h3>HTAs (Health Technology Assessments)</h3><!-- end field e55de209-9524-4b59-915b-25ccf47e812b --><!-- begin field b16c3eb5-8a32-42e7-8edd-f25364024f81 --><p>No new HTAs since 1 April 2019.</p><!-- end field b16c3eb5-8a32-42e7-8edd-f25364024f81 --><!-- begin field a8ebd12b-7b7e-4009-8116-bbb3786b213b --><h3>Economic appraisals</h3><!-- end field a8ebd12b-7b7e-4009-8116-bbb3786b213b --><!-- begin field e78ab603-4132-47e4-a6e7-ae0d32c1e845 --><p>No new economic appraisals relevant to England since 1 April 2019.</p><!-- end field e78ab603-4132-47e4-a6e7-ae0d32c1e845 --><!-- begin field 27008845-9180-4c9e-86a9-42dd6807c978 --><h3>Systematic reviews and meta-analyses</h3><!-- end field 27008845-9180-4c9e-86a9-42dd6807c978 --><!-- begin field 18ee37b0-ad44-4741-8762-1f47d871469f --><p>No new systematic review or meta-analysis since 1 April 2019</p><!-- end field 18ee37b0-ad44-4741-8762-1f47d871469f --><!-- begin field c68aeb7d-1411-4eb1-bfdc-e650eb98fa60 --><h3>Primary evidence</h3><!-- end field c68aeb7d-1411-4eb1-bfdc-e650eb98fa60 --><!-- begin field 2ae8225f-a1e4-4a09-ae69-76efb04eb4ff --><p>No new randomised controlled trials published in the major journals since 1 April 2019.</p><!-- end field 2ae8225f-a1e4-4a09-ae69-76efb04eb4ff --><!-- end item c3d855ae-1a92-48eb-a3bc-61a45efff882 -->","subChapters":[]},{"id":"37c1cadb-fbe3-55f6-98c2-bf3949b4f0c2","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field 9ab8cebe-46d5-4b41-987e-16d948b62254 --><h3>New policies</h3><!-- end field 9ab8cebe-46d5-4b41-987e-16d948b62254 -->","summary":null,"htmlStringContent":"<!-- begin item 37e90b38-1a27-4b02-8364-55ac1498e62d --><!-- begin field 8e5abd8e-45be-4865-b0a3-8c9b7f64eb4c --><p>No new national policies or guidelines since 1 April 2019.</p><!-- end field 8e5abd8e-45be-4865-b0a3-8c9b7f64eb4c --><!-- end item 37e90b38-1a27-4b02-8364-55ac1498e62d -->","subChapters":[]},{"id":"75d4aecd-a27f-585a-b1a8-136bdf9ce5ca","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field d4c1a08d-1414-446e-bf49-7321f5c4a2ed --><h3>New safety alerts</h3><!-- end field d4c1a08d-1414-446e-bf49-7321f5c4a2ed -->","summary":null,"htmlStringContent":"<!-- begin item 9665030d-9f81-4c17-a05e-bbd400675829 --><!-- begin field c09d912d-1b2d-41c6-969c-294e43d573cc --><p>No new safety alerts since 1 April 2019.</p><!-- end field c09d912d-1b2d-41c6-969c-294e43d573cc --><!-- end item 9665030d-9f81-4c17-a05e-bbd400675829 -->","subChapters":[]},{"id":"511ec8b6-793b-519d-acaf-5f813116d309","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field dcbd13b6-94db-4539-82c1-d440f5b3a109 --><h3>Changes in product availability</h3><!-- end field dcbd13b6-94db-4539-82c1-d440f5b3a109 -->","summary":null,"htmlStringContent":"<!-- begin item 9455e610-085a-4764-906b-e5de663bfee0 --><!-- begin field d7ae3aab-d953-4085-b85f-db2a1e24d9bf --><ul><li>A new SPC for a Trivalent Influenza Vaccine (Split Virion, Inactivated) High Dose, indicated for active immunisation in adults 65 years of age and older for the prevention of influenza disease. See more <a data-hyperlink-id=\"7012eb35-9e8c-4653-b7a8-aa4e0095d412\" href=\"https://www.medicines.org.uk/emc/product/10012/smpc\">here</a>.</li><li>Update on vaccines for 2019/20 seasonal flu vaccination programme, see more <a href=\"https://www.england.nhs.uk/wp-content/uploads/2019/01/vaccines-for-19-20-seasonal-flu-vaccination-programme.pdf\" data-hyperlink-id=\"7021366f-4539-4f8d-bf2d-aa8100b23602\">here</a>. </li></ul><!-- end field d7ae3aab-d953-4085-b85f-db2a1e24d9bf --><!-- end item 9455e610-085a-4764-906b-e5de663bfee0 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}